CEO: Helen I. Torley

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.


Key numbers

Market Capitalization:2606869000
Shares Outstanding: 136700000
Float: 128074777
Next Earning Date:2020-02-24
TTm EPS: -0.2741
TTm Dividend Rate:
200 days moving average:16.83
50 days moving average: 18.84
One day percent Change: -3



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,